McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey Davis. February 5, 2026 – Often in the policy realm (and especially in the health space), major reforms are ...

Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack competitive conditions. Learnings from transparency will shape future drug pricing ...

Transparency mandates require detailed disclosure of rebates, spread pricing, fees, and reimbursement methodologies, expanding plan sponsor audit rights and increasing CMS oversight of PBM reporting ...

There have been a series of court cases and federal legislation targeting the spread pricing model often used by pharmacy benefit managers (PBM). Spread pricing involves two points of time in ...

Jack Du has 3+ years of experience working with Brown Investment Group and 2+ years as an investment analyst. Anthony Battle is a CERTIFIED FINANCIAL PLANNER™ professional. He earned the Chartered ...

Pharmacy Benefit Managers (PBMs) play a large role in deciding which drugs patients receive and how much they pay. Yet their fees, rebates, and contracts remain largely hidden from employers, insurers ...

Hospitals are in a unique position when it comes to managing their pharmacy benefits because they often possess in-house pharmacy distribution capabilities and access to staff with clinical pharmacy ...